Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
IA-2A positivity could help develop effective intervention strategies in type 1 diabetes…
IA-2A identified as a key biomarker for type 1 diabetes risk stratification and early intervention strategies
H.E.L Group and ICT Mumbai sign research agreement to enhance process safety in chemical synthesis
H.E.L Group to provide simular reaction Calorimeter to ICT Mumbai for process safety research and education
Tenthpin Management Consultants launches AI labs in Hyderabad to drive life sciences Innovation
Global consulting firm Tenthpin establishes AI-focused Centre of Excellence in Hyderabad to accelerate AI adoption in Life…
IPA questions FAERS data interpretation in the Ohio State University study
The Indian Pharmaceutical Alliance (IPA) states that a higher rate of serious adverse events (SAEs) for drugs manufactured in…
Zydus Lifesciences receives USFDA approval for Methenamine Hippurate tablets
Approval allows Zydus to manufacture and market 1-gram Methenamine Hippurate tablets in the United States
Davaindia expands in Kerala to improve access to affordable generic medicines
With over 50 stores in Kerala, Davaindia aims to expand further into Tier 2 and rural areas while promoting awareness of generic…
Alkem Laboratories launches generic Empagliflozin in India at reduced cost
Empanorm and its combinations introduced at prices approximately 80 per cent lower than innovator products
Sun Pharma to acquire Checkpoint Therapeutics in oncology deal
Transaction to expand Sun Pharma’s onco-derm portfolio with FDA-approved treatment for advanced cSCC
Navigating Revised Schedule M: A roadmap for pharma MSMEs | 10th April 2025 | Agilent
10th April 2025 | 3:00 PM - 4:30 PM IST | Live Webinar
Glenmark USA launches Polyethylene Glycol 3350, Powder for Solution, 17 grams/capful (OTC)
It compares to the active ingredient in MiraLAX Powder for Solution, 17 grams of Bayer HealthCare